Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
Uploaded 6 days ago
Duration: 0h 4m 45s
USFDA's new draft biosimilar rules to benefit Indian biotech cos
The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.
Uploaded by: Rediff Video Desk on Sun, 09 Nov 2025 15:17:46 +0530
Views: 44
Tags: USFDA's new draft biosimilar rules to benefit Indian biotech cos
© 2025